| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:HPK1-IN-17
CAS:2403600-07-5
Package:25mg/RMB 10600;50mg/RMB 13800;100mg/RMB 17500
|
Benzamide, N,N-dimethyl-4-[2-[4-(4-methyl-1-piperazinyl)phenyl]-5H-pyrrolo[2,3-b]pyrazin-7-yl]- manufacturers
- HPK1-IN-17
-
- $1520.00 / 25mg
-
2025-10-27
- CAS:2403600-07-5
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | Benzamide, N,N-dimethyl-4-[2-[4-(4-methyl-1-piperazinyl)phenyl]-5H-pyrrolo[2,3-b]pyrazin-7-yl]- Basic information |
| | Benzamide, N,N-dimethyl-4-[2-[4-(4-methyl-1-piperazinyl)phenyl]-5H-pyrrolo[2,3-b]pyrazin-7-yl]- Chemical Properties |
| density | 1.232±0.06 g/cm3(Predicted) | | pka | 11.04±0.50(Predicted) |
| | Benzamide, N,N-dimethyl-4-[2-[4-(4-methyl-1-piperazinyl)phenyl]-5H-pyrrolo[2,3-b]pyrazin-7-yl]- Usage And Synthesis |
| Uses | HPK1-IN-17 is a potent and selective inhibitor of HPK1. Hematopoietic progenitor kinase 1 (HPKl) originally cloned from hematopoietic progenitor cells is a member of MAP kinase kinase kinase kinases (MAP4Ks) family. HPK1-IN-17 is useful in researching, preventing or ameliorating diseases or disorders associated with HPK1 activity such as cancer (extracted from patent WO2019238067A1, compound 73)[1]. | | References | [1] Jing Li, et al. Pyrrolo [2, 3-b] pyridines or pyrrolo [2, 3-b] pyrazines as hpk1 inhibitor and the use thereof. Patent WO2019238067A1. |
| | Benzamide, N,N-dimethyl-4-[2-[4-(4-methyl-1-piperazinyl)phenyl]-5H-pyrrolo[2,3-b]pyrazin-7-yl]- Preparation Products And Raw materials |
|